PH11122A - 19-hydroxy-androst-4-enes,pharmaceutical composition and method of use - Google Patents

19-hydroxy-androst-4-enes,pharmaceutical composition and method of use

Info

Publication number
PH11122A
PH11122A PH15463A PH15463A PH11122A PH 11122 A PH11122 A PH 11122A PH 15463 A PH15463 A PH 15463A PH 15463 A PH15463 A PH 15463A PH 11122 A PH11122 A PH 11122A
Authority
PH
Philippines
Prior art keywords
androst
enes
hydroxy
pharmaceutical composition
pharmaceutical
Prior art date
Application number
PH15463A
Other languages
English (en)
Inventor
V Petron
J Grunwell
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of PH11122A publication Critical patent/PH11122A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
PH15463A 1973-02-05 1974-01-31 19-hydroxy-androst-4-enes,pharmaceutical composition and method of use PH11122A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32984973A 1973-02-05 1973-02-05

Publications (1)

Publication Number Publication Date
PH11122A true PH11122A (en) 1977-10-27

Family

ID=23287276

Family Applications (1)

Application Number Title Priority Date Filing Date
PH15463A PH11122A (en) 1973-02-05 1974-01-31 19-hydroxy-androst-4-enes,pharmaceutical composition and method of use

Country Status (7)

Country Link
AU (1) AU472681B2 (pt)
BE (1) BE810457A (pt)
DE (1) DE2404332A1 (pt)
FR (1) FR2215972B1 (pt)
GB (1) GB1450439A (pt)
PH (1) PH11122A (pt)
ZA (1) ZA739584B (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB820779A (en) * 1954-12-08 1959-09-23 Syntex Sa Cyclopentanophenanthrene derivatives
FR1374356A (fr) * 1962-05-16 1964-10-09 Syntex Corp Procédé de préparation de dérivés du cyclopentanophénanthrène
NL123605C (pt) * 1963-06-19

Also Published As

Publication number Publication date
GB1450439A (en) 1976-09-22
AU6397673A (en) 1975-07-03
ZA739584B (en) 1974-11-27
DE2404332A1 (de) 1974-08-08
FR2215972B1 (pt) 1977-05-06
FR2215972A1 (pt) 1974-08-30
BE810457A (fr) 1974-05-16
AU472681B2 (en) 1976-06-03

Similar Documents

Publication Publication Date Title
PH11112A (en) Pyridoindoles,composition containing them and their method of use
PH9202A (en) N-substituted-4-diphenylmethylpiperidine derivatives,the compositions and method of use thereof
PH10476A (en) Hexahydro-dibenzo(b,d)pyran-9-ones,compositions containing them and method of use
PH11788A (en) Dihydroxyhexahydrodibenzo(b.d)pyrans derivatives,pharmaceutical composition and method of use thereof
IL45123A0 (en) 5-methyl-isoflavone-derivatives,process for preparation thereof and pharmaceutical compositions containing them
IL45516A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
IL44427A0 (en) Dibenzothiepine derivatives,their manufacture and pharmaceutical compositions containing them
IL44770A0 (en) New thiaprostaglandins,their manufacture and pharmaceutical compositions containing them
IL47329A0 (en) New pyridobenzodiazepinones,their preparation and pharmaceutical compositions containing them
PH11400A (en) Naphthyridine derivatives and pharmaceutical composition thereof
IL44222A0 (en) New diphenylpropylamines,their preparation and pharmaceutical compositions containing them
HK55876A (en) New pyrazol-5-ones, their preparation and their pharmaceutical use
IL50797A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL47196A0 (en) New 7-substituted-8-aminomethyl-isoflavone derivatives,their preparation and pharmaceutical compositions containing them
IL44895A0 (en) New thiazoloisoquinolines,their preparation and pharmaceutical compositions containing them
IL45995A0 (en) New substituted thiazole-2-carboxamides,their preparation and pharmaceutical compositions containing them
IL44849A0 (en) New nitrocarbostyrils,their preparation and pharmaceutical compositions containing them
IL48788A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
PH11219A (en) N-substituted-dihydroxyphenethylamine derivatives and pharmaceutical composition thereof
PH10450A (en) Alkylphenyl benzopyranopyridines,pharmaceutical compositions and method of use thereof
IL49847A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL44106A0 (en) New phenylguanidines,their preparation and pharmaceutical compositions containing them
PH12431A (en) 1-aryl-uracil,derivatives,pharmaceutical composition and method of use
ZA733340B (en) New 6alpha-methylprednisolone derivatives,preparation process and pharmaceutical compositions
IL47451A0 (en) New benzhydryloxy-alkylamine derivatives,their preparation and pharmaceutical compositions containing them